{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:40:41Z","timestamp":1788273641658,"version":"build-2803163510"},"reference-count":79,"publisher":"Elsevier","isbn-type":[{"value":"9780443296383","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.irn.2024.07.007","type":"book-chapter","created":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T07:20:11Z","timestamp":1723274411000},"page":"283-300","source":"Crossref","is-referenced-by-count":6,"title":["Ayahuasca for the treatment of alcohol use disorder"],"prefix":"10.1016","member":"78","reference":[{"issue":"10","key":"10.1016\/bs.irn.2024.07.007_bib1","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1021\/acschemneuro.8b00237","article-title":"Psychedelics and personality","volume":"9","author":"Aixal\u00e0","year":"2018","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/bs.irn.2024.07.007_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1074633","article-title":"Psilocybin sex-dependentlyreduces alcohol consumption in C57BL\/6J mice","author":"Alper","year":"2023","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2024.07.007_bib3","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00213-018-5106-2","article-title":"Microdosing psychedelics: Personality, mental health, and creativity differences in microdosers","volume":"236","author":"Anderson","year":"2019","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/bs.irn.2024.07.007_bib4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/dar.12985","article-title":"Exploring ayahuasca-assisted therapy for addiction: A qualitative analysis of preliminary findings among an Indigenous community in Canada","volume":"38","author":"Argento","year":"2019","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/bs.irn.2024.07.007_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.comppsych.2016.09.003","article-title":"Psychological and neuropsychological assessment of regular hoasca users","volume":"71","author":"Barbosa","year":"2016","journal-title":"Comprehensive Psychiatry"},{"key":"10.1016\/bs.irn.2024.07.007_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fpsyt.2018.00136","article-title":"Assessment of alcohol and tobacco use disorders among religious users of ayahuasca","volume":"9","author":"Barbosa","year":"2018","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/bs.irn.2024.07.007_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/1099-1077(200010)15:7<559::AID-HUP230>3.0.CO;2-J","article-title":"Hallucinogenicdrugs attenuate the subjective response to alcohol in humans","volume":"15","author":"Barrett","year":"2000","journal-title":"Human Psychopharmacology"},{"key":"10.1016\/bs.irn.2024.07.007_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/bs.pbr.2018.08.002","article-title":"A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder","volume":"242","author":"Barsuglia","year":"2018","journal-title":"Progress in Brain Research"},{"key":"10.1016\/bs.irn.2024.07.007_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuropharm.2018.02.018","article-title":"Psychedelics: Where we are now, why we got here, what we must do","volume":"142","author":"Belouin","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.irn.2024.07.007_bib10","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00213-023-06384-w","article-title":"Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memories","volume":"240","author":"Benvenuti","year":"2023","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2024.07.007_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pnpbp.2012.06.001","article-title":"Developments in harmine pharmacology \u2013 implications for ayahuasca use and drug-dependence treatment","volume":"39","author":"Brierley","year":"2012","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"5","key":"10.1016\/bs.irn.2024.07.007_bib12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/FBP.0000000000000628","article-title":"Effects of 5-HT2A receptor agonist 2,5-dimethoxy-4-iodoamphetamine on alcohol consumption in Long-Evans rats","volume":"32","author":"Berquist","year":"2021","journal-title":"Behavioural Pharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2024.07.007_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10943-014-9826-2","article-title":"Forbidden therapies: Santo daime, ayahuasca, and the prohibition of entheogens in western onkeys","volume":"54","author":"Blainey","year":"2014","journal-title":"Journal of Religion and Health"},{"key":"10.1016\/bs.irn.2024.07.007_bib14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/7854_2016_464","article-title":"Therapeutic applications of classic hallucinogens","volume":"36","author":"Bogenschutz","year":"2018","journal-title":"Current Topics in Behavioral Neurosciences"},{"key":"10.1016\/bs.irn.2024.07.007_bib15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybinassistedtreatment for alcohol dependence: A proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1016\/bs.irn.2024.07.007_bib16","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy\u00a0drinking days following psilocybin assisted psychotherapy vs placebo in the treatment of adult patients with alcoholuse disorder: A randomized clinical trial","volume":"9","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"P","key":"10.1016\/bs.irn.2024.07.007_bib17","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2174\/156802606778522131","article-title":"Serotonin 5-Ht2a and 5-Ht2c receptors as potential targets for modulation of psychostimulant use and dependence","volume":"6","author":"Bubar","year":"2006","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"10.1016\/bs.irn.2024.07.007_bib18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0079-6123(08)00916-3","article-title":"Prospects for onkeys\u00a0N 5-Ht2r pharmacotherapy in psychostimulant abuse","volume":"172","author":"Bubar","year":"2008","journal-title":"Progress in Brain Research"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2024.07.007_bib19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugalcdep.2010.03.015","article-title":"Dimethyltryptamine (DMT): Subjective effects and patterns of use among Australian recreational users","volume":"111","author":"Cakic","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/bs.irn.2024.07.007_bib20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41386-022-01389-z","article-title":"Towards na understanding of psychedelic-induced neuroplasticity","volume":"48","author":"Calder","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2024.07.007_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neuropharm.2017.11.028","article-title":"A regulatory perspective on the evaluation of hallucinogen drugs for human use","volume":"142","author":"Calderon","year":"2018","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/bs.irn.2024.07.007_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13229","article-title":"Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies","volume":"27","author":"Calleja-Conde","year":"2022","journal-title":"Addiction Biology"},{"issue":"242","key":"10.1016\/bs.irn.2024.07.007_bib23","first-page":"1","article-title":"An introduction to psychedelic neuroscience","volume":"2018","author":"Calvey","year":"2018","journal-title":"Progress in Brain Research"},{"key":"10.1016\/bs.irn.2024.07.007_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0378-8741(98)00168-8","article-title":"Pharmacokinetics of hosca alkaloids in health humans","volume":"65","author":"Callaway","year":"1999","journal-title":"Journal of Ethnopharmacology"},{"issue":"Pt1","key":"10.1016\/bs.irn.2024.07.007_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainresbull.2016.04.016","article-title":"Neuropharmacology of N,N,-dimethyltryptamine","volume":"126","author":"Carbonaro","year":"2016","journal-title":"Brain Research Bulletin"},{"issue":"11","key":"10.1016\/bs.irn.2024.07.007_bib26","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/npp.2017.84","article-title":"The therapeutic potential of psychedelic drugs: Past, present, and future","volume":"42","author":"Carhart-Harris","year":"2017","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"May","key":"10.1016\/bs.irn.2024.07.007_bib27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fphar.2018.00561","article-title":"Ayahuasca and its DMT- and \u00df-carbolines- containonkeysn.ents block onkeysn.siononkeyanol-induced conditioned place preference in mice: Role of the treatment environment","volume":"9","author":"Cata-Preta","year":"2018","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.irn.2024.07.007_bib28","first-page":"56","article-title":"Observations regarding the use of LSD-25 in the treatment of\u00a0alcoholism","volume":"1","author":"Cheek","year":"1966","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/bs.irn.2024.07.007_bib29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.15288\/qjsa.1959.20.577","article-title":"Use of d-lysergic acid diethylamide in the treatment of alcoholism","volume":"20","author":"Chwelos","year":"1959","journal-title":"Quarterly Journal of Studies on Alcohol"},{"key":"10.1016\/bs.irn.2024.07.007_bib30","first-page":"242","article-title":"D-Lysergic acid diethylamide, psilocybinonke other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders","author":"De Gregorio","year":"2018","journal-title":"Progress in Brain Research"},{"key":"10.1016\/bs.irn.2024.07.007_bib31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1192\/bjp.116.533.443","article-title":"A controlled study of LSD treatment in alcoholism and neurosis","volume":"116","author":"Denson","year":"1970","journal-title":"The British Journal of Psychiatry"},{"issue":"1\u20133","key":"10.1016\/bs.irn.2024.07.007_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-2999(99)00372-6","article-title":"Drug addiction as dopamine-dependent associative learning disorder","volume":"375","author":"Di Chiara","year":"1999","journal-title":"European Journal of Pharmacology"},{"issue":"12","key":"10.1016\/bs.irn.2024.07.007_bib33","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1007\/s11033-020-06009-x","article-title":"Psychedelina as an emerging novel intervention in the treatment of substance use disorder: A review","volume":"47","author":"DiVito","year":"2020","journal-title":"Molecular Biology Reports"},{"key":"10.1016\/bs.irn.2024.07.007_bib34","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3390\/cells12060963","article-title":"Psychedelic targeting of metabotropic glutamate receptor 2 and its implications for the treatment of alcoholism","volume":"12","author":"Domanegg","year":"2023","journal-title":"Cells"},{"key":"10.1016\/bs.irn.2024.07.007_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.brainresbull.2016.03.002","article-title":"Ayahuasca: Pharmacology, neuroscience and therapeutic potential","volume":"126","author":"Dom\u00ednguez-Clav\u00e9","year":"2016","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/bs.irn.2024.07.007_bib36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.15288\/qjsa.1967.28.295","article-title":"Treatment of alcoholism with lysergide","volume":"28","author":"Dusen","year":"1967","journal-title":"Quarterly Journal of Studies on Alcohol"},{"issue":"3","key":"10.1016\/bs.irn.2024.07.007_bib37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugalcdep.2010.03.024","article-title":"Assessment of addiction severity among ritual users of ayahuasca","volume":"111","author":"F\u00e1bregas","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/bs.irn.2024.07.007_bib38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00008877-200403000-00007","article-title":"Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in onkeys monkeys","volume":"15","author":"Fantegrossi","year":"2004","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/bs.irn.2024.07.007_bib39","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0079-6123(08)00918-7","article-title":"Serotonin receptors as potential targets for modulation of nicotine use and dependence","volume":"v. 172","author":"Fletcher","year":"2008","journal-title":"Progress in Brain Research"},{"key":"10.1016\/bs.irn.2024.07.007_bib40","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3389\/fpsyt.2019.00955","article-title":"Persisting reductions in cannabis opioid, and stimulant misuse after naturalistic psychedelic use: An online survey","volume":"10","author":"Garcia-Romeu","year":"2020","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/bs.irn.2024.07.007_bib41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bcp.2014.01.035","article-title":"Biosynthesis of N,N-dimethyltryptamine (DMT) in a melanoma cell line and its metabolization by peroxidases","volume":"88","author":"Gomes","year":"2014","journal-title":"Biochemical Pharmacology"},{"issue":"45","key":"10.1016\/bs.irn.2024.07.007_bib42","doi-asserted-by":"crossref","first-page":"8439","DOI":"10.1523\/JNEUROSCI.1121-22.2022","article-title":"Psychedelics and neural plasticity: Therapeutic implications","volume":"42","author":"Grieco","year":"2022","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2024.07.007_bib43","unstructured":"Grob, C.\u00a0(1998). 2. Psychiatric research with hallucinogens: What have we learned?\u00a0The Heffter Review of Psychedelic Research."},{"issue":"2","key":"10.1016\/bs.irn.2024.07.007_bib44","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2174\/1570159X16666180125095902","article-title":"Ayahuasca: Psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness","volume":"17","author":"Hamill","year":"2019","journal-title":"Current Neuropharmacology"},{"issue":"5","key":"10.1016\/bs.irn.2024.07.007_bib45","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00702-024-02757-3","article-title":"Epigenetic drugs and psychedelics as emerging therapies for alcohol use disorder: Insights from preclinical studies","volume":"131","author":"Hilal","year":"2024","journal-title":"Journal of Neural Transmission (Vienna)"},{"key":"10.1016\/bs.irn.2024.07.007_bib46","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/pr.114.009514","article-title":"Serotonin 5-Ht2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder","volume":"v. 67","author":"Howell","year":"2015","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/bs.irn.2024.07.007_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2835","article-title":"N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine","volume":"37","author":"James","year":"2022","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"key":"10.1016\/bs.irn.2024.07.007_bib48","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1176\/ajp.126.4.481","article-title":"LSD in the treatment of alcoholism","volume":"126","author":"Johnson","year":"1969","journal-title":"AJP"},{"key":"10.1016\/bs.irn.2024.07.007_bib49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-0028-1094301","article-title":"LSD in the treatment of alcoholics","volume":"4","author":"Kurland","year":"1971","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2024.07.007_bib50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/jpet.102.042184","article-title":"Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves","volume":"304","author":"Kurrasch-Orbaugh","year":"2003","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1016\/bs.irn.2024.07.007_bib51","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.drugpo.2010.09.002","article-title":"The expansion of the field of research on ayahuasca: Some reflections about the ayahuasca track at the MAPS \u201cPsychedelic Science in the 21st Century\u201d conference","volume":"22","author":"Labate","year":"2010","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/bs.irn.2024.07.007_bib52","first-page":"205","article-title":"The treatment and handling of substance dependence with ayahuasca: Reflections on urrent and future research","author":"Labate","year":"2010","journal-title":"Ayahuasca, Ritual and Religion in Brazil, N. January"},{"issue":"n. 2","key":"10.1016\/bs.irn.2024.07.007_bib53","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.drugpo.2011.06.006","article-title":"Ayahuasca and the process of regulation in brazil and internationally: Implications and challenges","volume":"v. 23","author":"Labate","year":"2012","journal-title":"International Journal of Drug Policy"},{"issue":"5","key":"10.1016\/bs.irn.2024.07.007_bib54","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00213-020-05477-0","article-title":"Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders","volume":"237","author":"Lea","year":"2020","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2024.07.007_bib55","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/02791072.2012.704590","article-title":"Hypotheses regarding the mechanisms of ayahuasca in the treatment of addictions","volume":"44","author":"Liester","year":"2012","journal-title":"Journal of Psychoactive Drugs"},{"issue":"1","key":"10.1016\/bs.irn.2024.07.007_bib56","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/02791072.2013.873157","article-title":"Therapeutic effects of ritual ayahuasca use in the treatment of substance dependence--qualitative results","volume":"46","author":"Loizaga-Velder","year":"2014","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/bs.irn.2024.07.007_bib57","doi-asserted-by":"crossref","first-page":"34","DOI":"10.15288\/qjsa.1961.22.034","article-title":"The use of LSD-25 in the treatment of alcoholism and other psychiatric problems","volume":"22","author":"Maclean","year":"1961","journal-title":"Quarterly Journal of Studies on Alcohol"},{"key":"10.1016\/bs.irn.2024.07.007_bib58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-2999(99)00125-9","article-title":"5-HT receptor ligands differentially affect operant oral self-administration of ethanol in the rat","volume":"370","author":"Maurel","year":"1999","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2024.07.007_bib59","doi-asserted-by":"crossref","first-page":"eabh2399","DOI":"10.1126\/sciadv.abh2399","article-title":"Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism","volume":"7","author":"Meinhardt","year":"2021","journal-title":"Science Advances"},{"key":"10.1016\/bs.irn.2024.07.007_bib60","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.lfs.2006.07.004","article-title":"Effects of \u03b2-carboline alkaloids on the object recognition task in mice","volume":"79","author":"Moura","year":"2006","journal-title":"Life Sciences"},{"key":"10.1016\/bs.irn.2024.07.007_bib61","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41398-020-01011-0","volume":"10","author":"Morales-Garcia","year":"2020","journal-title":"Translational Psychiatry"},{"key":"10.1016\/bs.irn.2024.07.007_bib62","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1038\/s41598-017-05407-9","article-title":"The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro","volume":"7","author":"Morales-Garc\u00eda","year":"2017","journal-title":"Scientific Reports"},{"issue":"242","key":"10.1016\/bs.irn.2024.07.007_bib63","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.pbr.2018.08.003","article-title":"The renaissance in psychedelic research: What do preclinical models have to offer","volume":"2018","author":"Murnane","year":"2018","journal-title":"Progress in Brain Research"},{"key":"10.1016\/bs.irn.2024.07.007_bib64","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0306-4522(02)00354-8","article-title":"Hallucinogens and Drosophila: Linking serotonin receptor activation to behavior","volume":"115","author":"Nichols","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/bs.irn.2024.07.007_bib65","doi-asserted-by":"crossref","unstructured":"Nichols,\u00a0D. E. (2016). Psychedelics|Pharmacological Reviews. 68(2), 264\u2013355. https:\/\/doi.org\/10.1124\/pr.115.011478. Erratum in: Pharmacological Reviews (2016). 68(2), 356. PMID: 26841800; PMCID: PMC4813425.","DOI":"10.1124\/pr.115.011478"},{"key":"10.1016\/bs.irn.2024.07.007_bib66","first-page":"331","article-title":"Lysergic acid and the alcoholic","volume":"23","author":"O\u2019reilly","year":"1962","journal-title":"Diseases of the Nervous System"},{"key":"10.1016\/bs.irn.2024.07.007_bib67","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.physbeh.2015.01.032","article-title":"Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice","volume":"v. 142","author":"Oliveira-Lima","year":"2015","journal-title":"Physiology and Behavior"},{"key":"10.1016\/bs.irn.2024.07.007_bib68","article-title":"Associations between ayahuasca consumption in naturalistic settings and current alcohol and drug use: Results of a large international cross-sectional survey","author":"Perkins","year":"2021","journal-title":"Drug and Alcohol Review"},{"issue":"7\u20138","key":"10.1016\/bs.irn.2024.07.007_bib69","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/dta.1344","article-title":"Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca","volume":"4","author":"Riba","year":"2012","journal-title":"Drug Testing and Analysis"},{"key":"10.1016\/bs.irn.2024.07.007_bib70","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/biom12111618","article-title":"Molecular pathways of the therapeutic effects of ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant","volume":"12","author":"Rossi","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/bs.irn.2024.07.007_bib71","first-page":"81","article-title":"Treatment of alcoholism withpsychotomimetic drugs. A follow-up study","volume":"20","author":"Rydzy\u0144ski","year":"1978","journal-title":"Activitas Nervosa Superior"},{"key":"10.1016\/bs.irn.2024.07.007_bib72","first-page":"273","article-title":"Prelminaryreport on the experience with psychosomimetic drugs in the treatment of alcobolism","volume":"10","author":"Rydzy\u0144ski","year":"1968","journal-title":"Activitas Nervosa Superior"},{"issue":"3","key":"10.1016\/bs.irn.2024.07.007_bib73","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1124\/pr.116.012484","article-title":"The nucleus accumbens: Mechanisms of addiction across drug classes reflect the importance of glutamate homeostasis","volume":"68","author":"Scofield","year":"2016","journal-title":"Pharmacological Reviews"},{"issue":"6","key":"10.1016\/bs.irn.2024.07.007_bib74","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s00213-022-06104-w","article-title":"Role of 5-Ht2a receptors in the effects of ayahuasca on ethanol self-administration using a two-bottle choice paradigm in male mice","volume":"239","author":"Serra","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2024.07.007_bib75","doi-asserted-by":"crossref","first-page":"406","DOI":"10.15288\/qjsa.1958.19.406","article-title":"A new adjunct to the treatment of alcoholism: The hallucinogenic drugs","volume":"19","author":"Smith","year":"1958","journal-title":"Quarterly Journal of Studies on Alcohol"},{"issue":"1","key":"10.1016\/bs.irn.2024.07.007_bib76","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/15733998113099990003","article-title":"Ayahuasca-assisted therapy for addiction: Results from a preliminary observational study in Canada","volume":"6","author":"Thomas","year":"2013","journal-title":"Current Drug Abuse Reviews"},{"issue":"5","key":"10.1016\/bs.irn.2024.07.007_bib77","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/cbf.2980","article-title":"Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor-reactive effect of peripheral blood mononuclear cells","volume":"31","author":"Tourino","year":"2013","journal-title":"Cell Biochemistry and Function"},{"key":"10.1016\/bs.irn.2024.07.007_bib78","unstructured":"World Health Organization (WHO). (2020). Psychoactive drugs. Global status report on alcohol and health. https:\/\/www.who.int\/health-topics\/drugs-psychoactive#tab=tab_1."},{"key":"10.1016\/bs.irn.2024.07.007_bib79","first-page":"225","article-title":"The role of serotonin 5-HT2A receptors in memory and cognition","author":"Zhang","year":"2015","journal-title":"Frontiers in Pharmacology, 6:article"}],"container-title":["International Review of Neurobiology","Advances in Alcohol Use Disorder Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S007477422400103X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S007477422400103X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T14:05:14Z","timestamp":1753797914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S007477422400103X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443296383"],"references-count":79,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2024.07.007","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}